Management

Niklas Prager

Niklas Prager

CEO

Niklas Prager has extensive and solid experience from the global pharma industry and has held leadership positions in research-focused pharmaceutical companies such as Merck/MSD and Pfizer, with both Sweden and the USA as a base. He has also been CEO and board member/chairperson of several medtech and biotech companies such as Medivir AB and CellaVision AB, and has experience with different types of ownership, from listed to private and private equity.
Nina Bauer

Nina Bauer

PhD, MBA, CBO and Head of SmartWise

A trained Neuroscientist, Nina’s career quickly centered on the Cell and Gene Therapy space, holding various technical and commercial roles at the Scottish Center for Regenerative Medicine (Edinburgh, UK) and the Cell and Gene Therapy Catapult (London, UK). She deepened her global commercial experience establishing Lonza’s autologous Cell Therapy Business and strategic positioning by incorporating the Cocoon™ technology with a vision for near-patient manufacturing (Basel, CH), as well as leading commercial teams at MilliporeSigma/Merck KGaA (Boston, USA) focusing on the Cell Therapy product portfolio, Gene Therapy manufacturing services and CRISPR IP licensing. Aside from large corporate and public sector leadership roles, Nina established her start-up and C-suite acumen as the Chief Commercial Officer for FloDesign Sonics (Wilbraham, USA), leading to the company’s acquisition by MilliporeSigma, as well as a wide range of advisory board engagements.
Johan Rugfelt

Johan Rugfelt

COO

  • CEO and COO Bactiguard ​
  • Business Sweden in Japan ​
  • Investment Banking at SEB ​
  • McKinsey and Bain​
  • M. Sc. In Business and Economics from Stockholm School of Economics.
Ricardo Baptista

Ricardo Baptista

PhD, CTO and Head of Procella

Ricardo is a Biotech Engineer with extensive experience in cell therapy globally, managing teams developing innovative bioprocess and analytical solutions for the scalable and affordable manufacture of cell therapies, at the likes of CCRM (CA), Cell and Gene Therapy Catapult (UK), Cellectis (FR), Procella Tx and Alder Tx (SE). He was involved in the generation of induced pluripotent stem cell (iPSC) lines in GMP, and on the design of GMP facilities for the large-scale manufacturing of cell and gene therapies. Ricardo combines extensive knowledge in CMC, Quality Assurance, and Regulatory Affairs, and is member of international committees and advisory boards propelling best practices to standardize development of iPSC therapies and novel therapeutic modalities. His strategic focus is to build agile teams to de-risk the product cycle from early world-class scientific discovery to commercial manufacture having the end product in mind since the start. Ricardo got his PhD degree at Instituto Superior Técnico (PT) and post-doctoral studies at Peter Zandstra Bioengineering Lab (CA).
Staffan Holmin

Staffan Holmin

MD, PhD, Scientific Advisor, CMO​

Staffan is one of the Founders of SmartCella and Professor in Clinical Neuroimaging in the department of Clinical Neuroscience, Karolinska Institutet and Senior physician/Consultant in endovascular neurointerventional procedures in the department of Neuroradiology, Karolinska University Hospital, as well as research group leader who has published widely on novel neuroimaging and interventional techniques. In 2016, he gave the Seldinger Honorary Lecture at the European Congress of Radiology. In 2020, he received the Hans Wigzell Foundation Science Prize.​
Jonathan Clarke

Jonathan Clarke

MD, Head of Research & Early Development

  • Medical degree cardiology at Harvard Medical
  • Internal Medicine at NYPH-Weil Cornell Cardiology
  • Fellowship at Massachusetts General Hospital
  • Research work at Karolinska Institutet focused on novel cardiac stem cell and RNA therapies for heart disease.
Kylie Foo

Kylie Foo

PhD, Head of SmartCella Solutions​

  • PhD in Neuroscience Karolinska Institutet
  • Fellow at Columbia University (New York) diabetes and stem cells.
  • Research at Karolinska Institutet aimed to translate cardiac stem cell therapy for treatment of heart disease.
Oskar Steneryd

Oskar Steneryd

CFO

  • MSc Business and Economics Stockholm School of Economics & HEC Paris (Accounting & Finance). ​
  • Formerly: Morgan Stanley Healthcare, Altor Private Equity, Novo Holdings, Impilo Private Equity
Ann Fredriksson

Ann Fredriksson

Head of HR & Internal Communication

Ann Fredriksson has extensive experience of senior HR and management positions from fast growing international businesses within Medtech, Biotech, IT and Software, companies such as Vironova AB and Jeeves Information Systems AB. She is a business-oriented HR professional with a sales & marketing background and has broad experience of working with organizations in change. Ann has held leadership positions at a strategic and operational level for more than 20 years and her competence covers the entire HR area with an emphasis on development and change management.